246 related articles for article (PubMed ID: 35301054)
1. Enhanced BBB and BBTB penetration and improved anti-glioma behavior of Bortezomib through dual-targeting nanostructured lipid carriers.
Farshbaf M; Mojarad-Jabali S; Hemmati S; Khosroushahi AY; Motasadizadeh H; Zarebkohan A; Valizadeh H
J Control Release; 2022 May; 345():371-384. PubMed ID: 35301054
[TBL] [Abstract][Full Text] [Related]
2. Liposome-Based Systemic Glioma-Targeted Drug Delivery Enabled by All-d Peptides.
Ying M; Zhan C; Wang S; Yao B; Hu X; Song X; Zhang M; Wei X; Xiong Y; Lu W
ACS Appl Mater Interfaces; 2016 Nov; 8(44):29977-29985. PubMed ID: 27797175
[TBL] [Abstract][Full Text] [Related]
3. Liposome-based glioma targeted drug delivery enabled by stable peptide ligands.
Wei X; Gao J; Zhan C; Xie C; Chai Z; Ran D; Ying M; Zheng P; Lu W
J Control Release; 2015 Nov; 218():13-21. PubMed ID: 26428462
[TBL] [Abstract][Full Text] [Related]
4. Peptide-22 and Cyclic RGD Functionalized Liposomes for Glioma Targeting Drug Delivery Overcoming BBB and BBTB.
Chen C; Duan Z; Yuan Y; Li R; Pang L; Liang J; Xu X; Wang J
ACS Appl Mater Interfaces; 2017 Feb; 9(7):5864-5873. PubMed ID: 28128553
[TBL] [Abstract][Full Text] [Related]
5. Dual-modified natural high density lipoprotein particles for systemic glioma-targeting drug delivery.
Cui L; Wang Y; Liang M; Chu X; Fu S; Gao C; Liu Q; Gong W; Yang M; Li Z; Yu L; Yang C; Su Z; Xie X; Yang Y; Gao C
Drug Deliv; 2018 Nov; 25(1):1865-1876. PubMed ID: 30474437
[TBL] [Abstract][Full Text] [Related]
6. Ligand-modified homologous targeted cancer cell membrane biomimetic nanostructured lipid carriers for glioma therapy.
Chen M; Cui Y; Hao W; Fan Y; Zhang J; Liu Q; Jiang M; Yang Y; Wang Y; Gao C
Drug Deliv; 2021 Dec; 28(1):2241-2255. PubMed ID: 34668811
[TBL] [Abstract][Full Text] [Related]
7. All-stage targeted therapy for glioblastoma based on lipid membrane coated cabazitaxel nanocrystals.
Wu S; Lu L; Zhou J; Ran D; Wang S; Xu Q; Xu W; Wang J; Liu Y; Xie C; Luo Z; Lu W
J Control Release; 2022 May; 345():685-695. PubMed ID: 35346767
[TBL] [Abstract][Full Text] [Related]
8. A novel peptide-drug conjugate for glioma-targeted drug delivery.
Zhou J; Meng N; Lu L; Lu J; Wu S; Ding Y; Wu S; Bao Y; Xu Q; Chen R; Wang J; Xie C; Wu J; Lu W
J Control Release; 2024 May; 369():722-733. PubMed ID: 38583575
[TBL] [Abstract][Full Text] [Related]
9. Glioma targeting peptide modified apoferritin nanocage.
Zhai M; Wang Y; Zhang L; Liang M; Fu S; Cui L; Yang M; Gong W; Li Z; Yu L; Xie X; Yang C; Yang Y; Gao C
Drug Deliv; 2018 Nov; 25(1):1013-1024. PubMed ID: 29726297
[TBL] [Abstract][Full Text] [Related]
10. LDLR-mediated peptide-22-conjugated nanoparticles for dual-targeting therapy of brain glioma.
Zhang B; Sun X; Mei H; Wang Y; Liao Z; Chen J; Zhang Q; Hu Y; Pang Z; Jiang X
Biomaterials; 2013 Dec; 34(36):9171-82. PubMed ID: 24008043
[TBL] [Abstract][Full Text] [Related]
11. Myristic Acid-Modified
Ying M; Wang S; Zhang M; Wang R; Zhu H; Ruan H; Ran D; Chai Z; Wang X; Lu W
ACS Appl Mater Interfaces; 2018 Jun; 10(23):19473-19482. PubMed ID: 29790744
[TBL] [Abstract][Full Text] [Related]
12. Dual-Modified Novel Biomimetic Nanocarriers Improve Targeting and Therapeutic Efficacy in Glioma.
Fu S; Liang M; Wang Y; Cui L; Gao C; Chu X; Liu Q; Feng Y; Gong W; Yang M; Li Z; Yang C; Xie X; Yang Y; Gao C
ACS Appl Mater Interfaces; 2019 Jan; 11(2):1841-1854. PubMed ID: 30582685
[TBL] [Abstract][Full Text] [Related]
13. Blood-Brain Barrier- and Blood-Brain Tumor Barrier-Penetrating Peptide-Derived Targeted Therapeutics for Glioma and Malignant Tumor Brain Metastases.
Chen L; Zeng D; Xu N; Li C; Zhang W; Zhu X; Gao Y; Chen PR; Lin J
ACS Appl Mater Interfaces; 2019 Nov; 11(45):41889-41897. PubMed ID: 31615203
[TBL] [Abstract][Full Text] [Related]
14. Design of Y-shaped targeting material for liposome-based multifunctional glioblastoma-targeted drug delivery.
Belhadj Z; Ying M; Cao X; Hu X; Zhan C; Wei X; Gao J; Wang X; Yan Z; Lu W
J Control Release; 2017 Jun; 255():132-141. PubMed ID: 28390902
[TBL] [Abstract][Full Text] [Related]
15. Vincristine and temozolomide combined chemotherapy for the treatment of glioma: a comparison of solid lipid nanoparticles and nanostructured lipid carriers for dual drugs delivery.
Wu M; Fan Y; Lv S; Xiao B; Ye M; Zhu X
Drug Deliv; 2016 Oct; 23(8):2720-2725. PubMed ID: 26203691
[TBL] [Abstract][Full Text] [Related]
16. Stapled RGD Peptide Enables Glioma-Targeted Drug Delivery by Overcoming Multiple Barriers.
Ruan H; Chen X; Xie C; Li B; Ying M; Liu Y; Zhang M; Zhang X; Zhan C; Lu W; Lu W
ACS Appl Mater Interfaces; 2017 May; 9(21):17745-17756. PubMed ID: 28497694
[TBL] [Abstract][Full Text] [Related]
17. Tailoring functional nanostructured lipid carriers for glioblastoma treatment with enhanced permeability through in-vitro 3D BBB/BBTB models.
Zwain T; Alder JE; Sabagh B; Shaw A; Burrow AJ; Singh KK
Mater Sci Eng C Mater Biol Appl; 2021 Feb; 121():111774. PubMed ID: 33579439
[TBL] [Abstract][Full Text] [Related]
18. Overcoming the blood-brain tumor barrier for effective glioblastoma treatment.
van Tellingen O; Yetkin-Arik B; de Gooijer MC; Wesseling P; Wurdinger T; de Vries HE
Drug Resist Updat; 2015 Mar; 19():1-12. PubMed ID: 25791797
[TBL] [Abstract][Full Text] [Related]
19. A comprehensive review in improving delivery of small-molecule chemotherapeutic agents overcoming the blood-brain/brain tumor barriers for glioblastoma treatment.
Wang D; Wang C; Wang L; Chen Y
Drug Deliv; 2019 Dec; 26(1):551-565. PubMed ID: 31928355
[TBL] [Abstract][Full Text] [Related]
20. A novel peptide ligand RAP12 of LRP1 for glioma targeted drug delivery.
Ruan H; Chai Z; Shen Q; Chen X; Su B; Xie C; Zhan C; Yao S; Wang H; Zhang M; Ying M; Lu W
J Control Release; 2018 Jun; 279():306-315. PubMed ID: 29679668
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
